Supreme Court: Foreign Companies’ Head Office Expenses in India are Capped under Section 44C  ||  SC Directs Trial Courts to Systematically Catalogue Witnesses and Evidence in Criminal Judgments  ||  SC Calls For Sensitising Future Generations on Equality in Marriage to Combat Dowry Practices  ||  SC: Separate Suits Against Confirmed Auction Sales are Barred; Remedy Available under Sec 47  ||  NCLT Mumbai: Oppression Claims Against Majority Shareholders Do not Justify Winding up a Company  ||  J&K&L HC Rules it Illegal and Inequitable to Deny Regularisation to a Daily Wager After 34 Years  ||  J&K&L High Court: Revisional Powers Must Be Used Within Reasonable Time; Merits Don’t Justify Delay  ||  Supreme Court: Compassionate Appointees Cannot Later Claim Entitlement to a Higher Post  ||  NCLAT New Delhi: Insolvency Pleas Cannot Be Admitted When Information Utility Records Show a Dispute  ||  NCLAT: Issuing Cheques For Another Entity’s Liabilities Does not Constitute Operational Debt    

AAR: Pharmaceutical Reference Standards is Not Diagnostic Reagent, Attracts 18% IGST - (22 Jan 2020)

GOODS AND SERVICES TAX

Authority on Advance Ruling, Karnataka has ruled that the Pharmaceutical Reference Standards (PRS) is not a diagnostic reagent and is not covered under Entry No. 80 of Schedule II of Integrated Goods and Services Tax Act, 2017 (IGST Act). The Authority clarified that PRS is covered under Entry no. 453 of Schedule III of IGST Act, attracting IGST at 18%.

Tags : AUTHORITY FOR ADVANCE RULING   PHARMACEUTICAL REFERENCE STANDARDS  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved